Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers (ProT4)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by University College, London
Sponsor:
Information provided by (Responsible Party):
University College, London
ClinicalTrials.gov Identifier:
NCT01240525
First received: November 11, 2010
Last updated: November 7, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2019
  Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)